TIMOPTIC Side Effects

5347868-2 | Blepharoplasty, Conjunctival Oedema, Dermatitis, Ectropion, Erythema, Periorbital Oedema, Skin Exfoliation
on Jun 01, 2007 Male patient from UNITED KINGDOM , 76 years of age, was diagnosed with open angle glaucoma and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation. Timoptic dosage: . During the same period patient was treated with ALPHAGAN (View Alphagan Review and Alphagan Label ), TRUSOPT (View Trusopt Review and Trusopt Label ), XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

5322953-X | Blepharoplasty, Conjunctival Oedema, Dermatitis, Ectropion, Erythema, Periorbital Oedema, Skin Exfoliation
Patient was taking Timoptic (View Usage). Patient had the following side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation on May 08, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 76 years of age, was diagnosed with open angle glaucoma and. Timoptic dosage: . During the same period patient was treated with ALPHAGAN (View Alphagan Review and Alphagan Label ), TRUSOPT (View Trusopt Review and Trusopt Label ), XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

5319665-5 | Atrial Fibrillation, Blood Cholesterol Increased, Cardiac Arrest, Dilatation Atrial, Hypotension, Mitral Valve Incompetence, Tricuspid Valve Incompetence, Ventricular Hypertrophy
Adverse event was reported on May 03, 2007 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: ITALY , 59 years of age, After Timoptic was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood cholesterol increased, cardiac arrest (What is cardiac arrest?), dilatation atrial, hypotension, mitral valve incompetence, tricuspid valve incompetence, ventricular hypertrophy. During the same period patient was treated with PROPAFENONE HYDROCHLORIDE (View Propafenone Hydrochloride Review and Propafenone Hydrochloride Label ), HEPARIN LOW MOLECULAR WEIGHT (View Heparin Low Molecular Weight Review and Heparin Low Molecular Weight Label ). Patient was hospitalized.

5310528-8 | Sinoatrial Block
on Apr 19, 2007 Female patient from FRANCE , 63 years of age, weighting 112.4 lb, was diagnosed with glaucoma (What is glaucoma?), diabetes mellitus insulin-dependent, hypertension and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: sinoatrial block. Timoptic dosage: . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ). Patient was hospitalized.


5310523-9 | Ectropion
on Apr 18, 2007 Male patient from UNITED KINGDOM , 76 years of age, was diagnosed with open angle glaucoma and was treated with Timoptic (View Usage). Patient had the following side effects: ectropion. Timoptic dosage: . During the same period patient was treated with ALPHAGAN (View Alphagan Review and Alphagan Label ), TRUSOPT (View Trusopt Review and Trusopt Label ), XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

5281163-5 | Blepharoplasty, Conjunctival Oedema, Dermatitis, Ectropion, Erythema, Periorbital Oedema, Skin Exfoliation
Patient was taking Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation on Mar 19, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 76 years of age, was diagnosed with open angle glaucoma and. Timoptic dosage: . During the same period patient was treated with BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), TRUSOPT (View Trusopt Review and Trusopt Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ). Patient was hospitalized.

5267358-5 | Deafness, Dizziness, Tinnitus
Adverse event was reported on Mar 13, 2007 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED KINGDOM , 67 years of age, Patient experienced the following unwanted or unexpected effects: deafness, dizziness (What is dizziness?), tinnitus (What is tinnitus?). During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ).

5258203-2 | Accidental Overdose, Dry Eye, Eye Pain, Intraocular Pressure Increased, Myocardial Infarction
on Mar 01, 2007 Male patient from UNITED KINGDOM , 78 years of age, weighting 165.3 lb, was diagnosed with glaucoma (What is glaucoma?), ischaemic heart disease prophylaxis, myocardial ischaemia, dyspepsia, hypertension, lipids increased and was treated with Timoptic (View Usage). Patient had the following side effects: accidental overdose, dry eye, eye pain, intraocular pressure increased, myocardial infarction. Timoptic dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

5254576-5 | Conjunctival Disorder, Hypopyon, Ulcerative Keratitis
on Feb 21, 2007 Female patient from JAPAN , 70 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: conjunctival disorder, hypopyon, ulcerative keratitis. Timoptic dosage: . During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

5254571-6 | Accidental Overdose, Dry Eye, Eye Pain, Intraocular Pressure Increased, Myocardial Infarction
Patient was taking Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, dry eye, eye pain, intraocular pressure increased, myocardial infarction on Feb 20, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 78 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Timoptic dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

5205373-8 | Brain Neoplasm, Dysgeusia, Feeling Abnormal, Gallbladder Disorder, Transient Ischaemic Attack
Adverse event was reported on Jan 04, 2007 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , 76 years of age, Patient had the following side effects: brain neoplasm, dysgeusia, feeling abnormal, gallbladder disorder, transient ischaemic attack. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), MYSOLINE (View Mysoline Review and Mysoline Label ), LOTREL (View Lotrel Review and Lotrel Label ).

5176395-0 | Diabetic Hyperglycaemic Coma
on Dec 08, 2006 Female patient from UNITED STATES , 30 years of age, was diagnosed with intraocular pressure test and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: diabetic hyperglycaemic coma. Timoptic dosage: . Patient was hospitalized and became disabled.

5174412-5 | Optic Neuritis
on Dec 05, 2006 Female patient from FRANCE , 57 years of age, was diagnosed with open angle glaucoma, essential hypertension and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: optic neuritis. Timoptic dosage: Unk. During the same period patient was treated with KERLONE (Unk) (View Kerlone Review and Kerlone Label ). Patient was hospitalized.

5162351-5 | Chest Pain, Dyspnoea Exertional
Patient was taking Timoptic (View Usage). Patient had the following side effects: chest pain (What is chest pain?), dyspnoea exertional on Nov 22, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 70 years of age, was diagnosed with glaucoma (What is glaucoma?), arthralgia, heart rate, migraine (What is migraine?) and. Timoptic dosage: . During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ), ACETAMINOPHEN AND PROPOXYPHENE HYDROCHLORIDE (View Acetaminophen And Propoxyphene Hydrochloride Review and Acetaminophen And Propoxyphene Hydrochloride Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), SUMATRIPTAN (View Sumatriptan Review and Sumatriptan Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

5151375-X | Corneal Deposits
Adverse event was reported on Nov 10, 2006 by a Male patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with keratitis herpetic and. Location: UNITED KINGDOM , 72 years of age, After Timoptic was administered, patient had the following side effects: corneal deposits. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ).

5148462-9 | Sudden Hearing Loss
on Oct 24, 2006 Male patient from GERMANY , 74 years of age, was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: sudden hearing loss. Timoptic dosage: . During the same period patient was treated with CORTISONE ACETATE (View Cortisone Acetate Review and Cortisone Acetate Label ), TERBINAFINE (View Terbinafine Review and Terbinafine Label ). Patient was hospitalized.

5148448-4 | Dyspnoea, Hyperventilation
on Nov 06, 2006 Female patient from UNITED KINGDOM , 82 years of age, weighting 282.2 lb, was diagnosed with glaucoma (What is glaucoma?), diabetes mellitus, hypertension and was treated with Timoptic (View Usage). Patient had the following side effects: dyspnoea, hyperventilation. Timoptic dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), XALATAN (View Xalatan Review and Xalatan Label ).

5141489-2 | Bradycardia, Respiratory Disorder
Patient was taking Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: bradycardia, respiratory disorder on Oct 26, 2006 from UNITED KINGDOM Additional patient health information: Male patient , 82 years of age, . Timoptic dosage: . Patient was hospitalized.

5119707-6 | Asthenopia, Eye Infection, Eye Irritation, Paralysis
Adverse event was reported on Sep 06, 2006 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , 89 years of age, Patient experienced the following unwanted or unexpected effects: asthenopia, eye infection (What is eye infection?), eye irritation, paralysis (What is paralysis?).

5118057-1 | Asthenopia, Eye Infection, Eye Irritation, Paralysis
on Sep 06, 2006 Female patient from UNITED STATES , 89 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). Patient had the following side effects: asthenopia, eye infection (What is eye infection?), eye irritation, paralysis (What is paralysis?). Timoptic dosage: .

5114323-4 | Alopecia Areata, Hyperthyroidism
on Sep 15, 2006 Female patient from DENMARK , 47 years of age, weighting 127.9 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: alopecia areata, hyperthyroidism. Timoptic dosage: .

5102598-7 | Blood Potassium Increased, Kidney Fibrosis, Renal Tubular Acidosis
Patient was taking Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased, kidney fibrosis, renal tubular acidosis on Feb 10, 2006 from JAPAN Additional patient health information: Female patient , 51 years of age, weighting 114.6 lb, was diagnosed with glaucoma (What is glaucoma?) and. Timoptic dosage: . During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

5078287-4 | Breast Cancer Metastatic, Cataract Nuclear, Cataract Subcapsular, Keratopathy, Metastases To Central Nervous System, Metastases To Lymph Nodes, Vocal Cord Paralysis
Adverse event was reported on May 18, 2006 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with intraocular pressure increased, conjunctival hyperaemia, conjunctivitis and. Location: JAPAN , 56 years of age, weighting 108.0 lb, Patient had the following side effects: breast cancer metastatic, cataract nuclear, cataract subcapsular, keratopathy, metastases to central nervous system, metastases to lymph nodes, vocal cord paralysis. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), FLUMETHOLON (View Flumetholon Review and Flumetholon Label ). Patient was hospitalized.

5060883-1 | Blood Potassium Increased, Kidney Fibrosis, Renal Tubular Acidosis
on Feb 10, 2006 Female patient from JAPAN , 51 years of age, weighting 114.6 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: blood potassium increased, kidney fibrosis, renal tubular acidosis. Timoptic dosage: . During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

5058674-0 | Blood Potassium Increased, Metabolic Acidosis, Renal Failure, Renal Tubular Acidosis, Soft Tissue Disorder
on Feb 10, 2006 Female patient from JAPAN , 51 years of age, weighting 114.6 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased, metabolic acidosis, renal failure, renal tubular acidosis, soft tissue disorder. Timoptic dosage: . During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

5039020-5 | Breast Cancer Metastatic, Cataract Nuclear, Cataract Subcapsular, Ciliary Hyperaemia, Conjunctival Hyperaemia, Dysphonia, Iris Adhesions, Keratitis
Patient was taking Timoptic (View Usage). Patient had the following side effects: breast cancer metastatic, cataract nuclear, cataract subcapsular, ciliary hyperaemia, conjunctival hyperaemia, dysphonia, iris adhesions, keratitis on May 18, 2006 from JAPAN Additional patient health information: Female patient , 56 years of age, weighting 108.0 lb, was diagnosed with intraocular pressure increased, conjunctival hyperaemia, conjunctivitis and. Timoptic dosage: . During the same period patient was treated with CRAVIT (View Cravit Review and Cravit Label ), FLUMETHOLON (View Flumetholon Review and Flumetholon Label ). Patient was hospitalized.

5028532-6 | Asthenia, Cataract Nuclear, Cataract Subcapsular, Hypersomnia, Keratitis, Keratopathy, Metastases To Central Nervous System, Metastases To Lymph Nodes, Oral Intake Reduced
Adverse event was reported on May 18, 2006 by a Female patient taking Timoptic (View Usage) (Dosage: ) . Location: JAPAN , 56 years of age, After Timoptic was administered, patient had the following side effects: asthenia, cataract nuclear, cataract subcapsular, hypersomnia, keratitis, keratopathy, metastases to central nervous system, metastases to lymph nodes, oral intake reduced. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), FLUOROMETHOLONE (View Fluorometholone Review and Fluorometholone Label ), BRINZOLAMIDE (View Brinzolamide Review and Brinzolamide Label ), HYALURONATE SODIUM (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ).

5017270-1 | Cataract Nuclear, Cataract Subcapsular, Corneal Disorder, Dysphonia, Keratopathy, Metastases To Lymph Nodes, Somnolence, Treatment Noncompliance, Vocal Cord Paralysis
on May 18, 2006 Female patient from JAPAN , 56 years of age, was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: cataract nuclear, cataract subcapsular, corneal disorder, dysphonia, keratopathy, metastases to lymph nodes, somnolence, treatment noncompliance, vocal cord paralysis. Timoptic dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), FLUOROMETHOLONE (View Fluorometholone Review and Fluorometholone Label ), BRINZOLAMIDE (View Brinzolamide Review and Brinzolamide Label ), HYALURONATE SODIUM (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ).

5011982-1 | Cataract Nuclear, Cataract Subcapsular, Corneal Disorder, Keratopathy, Metastases To Lymph Nodes, Vocal Cord Paralysis
on May 18, 2006 Female patient from JAPAN , 56 years of age, was treated with Timoptic (View Usage). Patient had the following side effects: cataract nuclear, cataract subcapsular, corneal disorder, keratopathy, metastases to lymph nodes, vocal cord paralysis. Timoptic dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), FLUOROMETHOLONE (View Fluorometholone Review and Fluorometholone Label ), BRINZOLAMIDE (View Brinzolamide Review and Brinzolamide Label ), HYALURONATE SODIUM (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ).

5009146-0 | Deafness, Dizziness, Tinnitus
Patient was taking Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: deafness, dizziness (What is dizziness?), tinnitus (What is tinnitus?) on Mar 31, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 67 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Timoptic dosage: . During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ).

4969721-6 | Deafness
Adverse event was reported on Apr 03, 2006 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED KINGDOM , 50 years of age, Patient experienced the following unwanted or unexpected effects: deafness.

4968488-5 | Deafness, Dizziness
on Mar 31, 2006 Female patient from UNITED KINGDOM , 67 years of age, was treated with Timoptic (View Usage). Patient had the following side effects: deafness, dizziness (What is dizziness?). Timoptic dosage: . During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ).

4939727-1 | Blood Creatinine Increased, Blood Potassium Increased, Renal Failure
on Feb 10, 2006 Female patient from JAPAN , 51 years of age, weighting 114.6 lb, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: blood creatinine increased, blood potassium increased, renal failure. Timoptic dosage: . During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

4937603-1 | Blood Creatinine Increased, Blood Potassium Increased, Renal Failure
Patient was taking Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood potassium increased, renal failure on Feb 10, 2006 from JAPAN Additional patient health information: Female patient , 51 years of age, weighting 114.6 lb, was diagnosed with glaucoma (What is glaucoma?) and. Timoptic dosage: . During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

4929937-1 | Blood Creatinine Increased, Blood Potassium Increased, Renal Failure
Adverse event was reported on Feb 10, 2006 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?) and. Location: JAPAN , 51 years of age, weighting 114.6 lb, Patient had the following side effects: blood creatinine increased, blood potassium increased, renal failure. During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

4918059-1 | Blood Creatinine Increased, Blood Potassium Increased
on Feb 10, 2006 Female patient from JAPAN , 51 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: blood creatinine increased, blood potassium increased. Timoptic dosage: . During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ).

4899280-8 | Eye Irritation, Headache
on May 04, 2005 Female patient from UNITED STATES , 84 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: eye irritation, headache (What is headache?). Timoptic dosage: Hs/opht. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

4840390-9 | Bradycardia
Patient was taking Timoptic (View Usage). Patient had the following side effects: bradycardia on Jan 18, 2005 from UNITED STATES Additional patient health information: Female patient , 80 years of age, . Timoptic dosage: Opht. Patient was hospitalized.

4822225-3 | Blood Pressure Increased, Gastrointestinal Haemorrhage, Haematoma, Thrombocytopenic Purpura
Adverse event was reported on Apr 07, 2005 by a Male patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?), essential hypertension and. Location: FRANCE , 59 years of age, weighting 220.5 lb, After Timoptic was administered, patient had the following side effects: blood pressure increased, gastrointestinal haemorrhage, haematoma, thrombocytopenic purpura. During the same period patient was treated with TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), HYDROCHLOROTHIAZIDE AND CANDESARTAN CILEXETIL (View Hydrochlorothiazide And Candesartan Cilexetil Review and Hydrochlorothiazide And Candesartan Cilexetil Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ). Patient was hospitalized.

4807924-1 | Antinuclear Antibody, Blood Pressure Increased, Hypersplenism, Thrombocytopenic Purpura
on Apr 07, 2005 Male patient from FRANCE , 59 years of age, weighting 220.5 lb, was diagnosed with glaucoma (What is glaucoma?), essential hypertension and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: antinuclear antibody, blood pressure increased, hypersplenism, thrombocytopenic purpura. Timoptic dosage: . During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (View Candesartan Cilexetil And Hydrochlorothiazide Review and Candesartan Cilexetil And Hydrochlorothiazide Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), BENAZEPRIL HCL (View Benazepril Hcl Review and Benazepril Hcl Label ). Patient was hospitalized.

4805366-6 | Adverse Event, Corneal Disorder, Glaucoma, Intraocular Pressure Test Abnormal
on Oct 04, 2005 Male patient from AUSTRALIA , 77 years of age, was treated with Timoptic (View Usage). Patient had the following side effects: adverse event, corneal disorder, glaucoma (What is glaucoma?), intraocular pressure test abnormal. Timoptic dosage: . During the same period patient was treated with TIMPILO (View Timpilo Review and Timpilo Label ).

4805257-0 | Adverse Event, Corneal Disorder, Glaucoma, Intraocular Pressure Test Abnormal
Patient was taking Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: adverse event, corneal disorder, glaucoma (What is glaucoma?), intraocular pressure test abnormal on Apr 13, 2005 from AUSTRALIA Additional patient health information: Male patient , 77 years of age, . Timoptic dosage: . During the same period patient was treated with TIMPILO (View Timpilo Review and Timpilo Label ).

4803147-0 | Adverse Event, Corneal Disorder, Glaucoma, Intraocular Pressure Test Abnormal
Adverse event was reported on Oct 04, 2005 by a Male patient taking Timoptic (View Usage) (Dosage: ) . Location: AUSTRALIA , 77 years of age, Patient experienced the following unwanted or unexpected effects: adverse event, corneal disorder, glaucoma (What is glaucoma?), intraocular pressure test abnormal. During the same period patient was treated with TIMPILO (View Timpilo Review and Timpilo Label ).

4799034-7 | Surgical Procedure Repeated
on Oct 04, 2005 Male patient from JAPAN , 32 years of age, was treated with Timoptic (View Usage). Patient had the following side effects: surgical procedure repeated. Timoptic dosage: . During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ), CARBACHOL (View Carbachol Review and Carbachol Label ), ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ). Patient was hospitalized.

4797438-X | Application Site Irritation, Eye Irritation, Eye Pain
on Oct 06, 2005 Female patient from UNITED STATES , weighting 120.0 lb, was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: application site irritation, eye irritation, eye pain. Timoptic dosage: One Drop In Each Eye Twice Daily Ophthalmic.

4748084-5 | Bradycardia
Patient was taking Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia on Aug 10, 2005 from UNITED KINGDOM Additional patient health information: Female patient , 81 years of age, was diagnosed with glaucoma (What is glaucoma?), hypertension, blood pressure (What is blood pressure?), blood cholesterol increased and. Timoptic dosage: . During the same period patient was treated with DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), BRINZOLAMIDE (View Brinzolamide Review and Brinzolamide Label ), CYCLOPENTOLATE HYDROCHLORIDE (View Cyclopentolate Hydrochloride Review and Cyclopentolate Hydrochloride Label ), TRAVOPROST (View Travoprost Review and Travoprost Label ). Patient was hospitalized.

4667801-6 | Dry Mouth, Gingival Disorder, Gynaecomastia, Hair Growth Abnormal, Myocardial Infarction, Pollakiuria, Tooth Loss
Adverse event was reported on Sep 05, 1996 by a Male patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with benign prostatic hyperplasia and. Location: , 75 years of age, Patient had the following side effects: dry mouth, gingival disorder, gynaecomastia, hair growth abnormal, myocardial infarction, pollakiuria, tooth loss. During the same period patient was treated with PROSCAR (View Proscar Review and Proscar Label ), IOPIDINE (View Iopidine Review and Iopidine Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ZOCOR (View Zocor Review and Zocor Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ).

4661880-8 | Atrioventricular Block Second Degree, Bradycardia, Dyspnoea, Exercise Tolerance Decreased
on May 10, 2005 Female patient from , 80 years of age, was diagnosed with glaucoma (What is glaucoma?), essential hypertension, hypothyroidism, angina pectoris and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: atrioventricular block second degree, bradycardia, dyspnoea, exercise tolerance decreased. Timoptic dosage: . During the same period patient was treated with VERAPAMIL HYDROCHLORIDE (View Verapamil Hydrochloride Review and Verapamil Hydrochloride Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

4643163-5 | Adverse Event, Corneal Disorder, Intraocular Pressure Test Abnormal
on Apr 13, 2005 Male patient from , 77 years of age, was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: adverse event, corneal disorder, intraocular pressure test abnormal. Timoptic dosage: . During the same period patient was treated with TIMPILO (View Timpilo Review and Timpilo Label ).

4633380-2 | Thrombocytopenic Purpura
Patient was taking Timoptic (View Usage). Patient had the following side effects: thrombocytopenic purpura on Apr 07, 2005 from Additional patient health information: Male patient , 59 years of age, weighting 220.5 lb, was diagnosed with glaucoma (What is glaucoma?), essential hypertension and. Timoptic dosage: . During the same period patient was treated with TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (View Candesartan Cilexetil And Hydrochlorothiazide Review and Candesartan Cilexetil And Hydrochlorothiazide Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), BENAZEPRIL HYDROCHLORIDE (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ). Patient was hospitalized.